PIM
JUNO

Platinum Investment Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Platinum Investment Management’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-24,895
Closed -$948K – 83
2016
Q1 		$948K Sell
24,895
-15,105
-38% -$526K 0.02% 72
2015
Q4 		$1.76M Hold
40,000
– – 0.04% 54
2015
Q3 		$1.63M Hold
40,000
– – 0.04% 53
2015
Q2 		$2.13M Hold
40,000
– – 0.04% 53
2015
Q1 		$2.43M Hold
40,000
– – 0.05% 60
2014
Q4 		$2.09M Buy
+40,000
New +$1.79M 0.04% 66

Other funds holding JUNO

CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Platinum Investment Management's JUNO Position: Q2 2016 in Review

Platinum Investment Management sold out of Juno Therapeutics, Inc. (JUNO) in Q2 2016, closing a stake of 24,895 shares — an estimated $948K sold.

Platinum Investment Management first reported a position in JUNO in Q4 2014 and held it in 6 quarters. The position peaked at $2.43M in Q1 2015. 170 funds tracked by Wall St. Rank hold JUNO as of Q2 2016.

  • Platinum Investment Management reported no remaining Juno Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • Platinum Investment Management sold 24,895 Juno Therapeutics, Inc. shares in Q2 2016, an estimated $948K.
  • Platinum Investment Management first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 6 quarters.
  • Platinum Investment Management's Juno Therapeutics, Inc. position peaked at $2.43M in Q1 2015.
  • 170 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q2 2016.

Based on Platinum Investment Management's 13F filing for Q2 2016, filed 12 Aug 2016.